[1]李 娟,孙 艺,韩宇博,等.中医药调控PPARγ相关信号通路治疗胰岛素抵抗研究进展[J].陕西中医,2025,46(5):712-716.[doi:DOI:10.3969/j.issn.1000-7369.2025.05.030]
 LI Juan,SUN Yi,HAN Yubo,et al.Research progress on the regulation of PPAR γ-related signaling pathway by traditional chinese medicine in the treatment of insulin resistance[J].,2025,46(5):712-716.[doi:DOI:10.3969/j.issn.1000-7369.2025.05.030]
点击复制

中医药调控PPARγ相关信号通路治疗胰岛素抵抗研究进展
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
46
期数:
2025年5期
页码:
712-716
栏目:
综 述
出版日期:
2025-05-05

文章信息/Info

Title:
Research progress on the regulation of PPAR γ-related signaling pathway by traditional chinese medicine in the treatment of insulin resistance
作者:
李 娟1孙 艺2韩宇博2孙全昊1李佳睿1杜丽坤2
(1.黑龙江中医药大学,黑龙江 哈尔滨 150000; 2.黑龙江中医药大学附属第一医院,黑龙江 哈尔滨 150000)
Author(s):
LI Juan1SUN Yi2HAN Yubo2SUN Quanhao1LI Jiarui1DU Likun2
(1.Heilongjiang University of Chinese Medicine,Harbin 150000,China; 2.The First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin 150000,China)
关键词:
过氧化物酶体增殖物激活受体γ 胰岛素抵抗 中医药 炎症 内质网应激 白色脂肪棕色化
Keywords:
Peroxisome proliferator-activated receptor gamma Insulin resistance Traditional Chinese medicine Inflammation Endoplasmic reticulum stress White adipose tissue browning
分类号:
R 587.1
DOI:
DOI:10.3969/j.issn.1000-7369.2025.05.030
文献标志码:
A
摘要:
胰岛素抵抗(IR)是糖尿病、肥胖、非酒精性脂肪性肝病和多囊卵巢综合征等代谢性疾病的“共同土壤”,其发病机制较为复杂。研究发现,过氧化物酶体增殖物激活受体γ(PPARγ)是治疗胰岛素抵抗的关键信号分子,本文基于近几年中药干预PPARγ信号治疗胰岛素抵抗的国内外文献进行总结,发现PPARγ靶向的下游信号分子主要包括核因子-κB(NF-κB)、磷脂酰肌醇-3-激酶(PI3K)、解偶联蛋白1(UCP1)和肝X受体α(LXR-α)等,通过改善胰岛素靶器官的炎症反应、氧化应激、内质网应激和线粒体功能障碍等机制来发挥减重、降糖降脂和改善胰岛素抵抗的作用。通过归纳总结共发现14种中药单体和7个中药复方通过调控PPARγ信号通路改善胰岛素抵抗,以期为中医药治疗胰岛素抵抗及相关疾病提供理论依据,并为临床研究和新药开发提供新思路。
Abstract:
Insulin resistance(IR)is the “common soil” for metabolic diseases such as diabetes,obesity,non-alcoholic fatty liver disease,and polycystic ovary syndrome.Its pathogenesis is complex.Studies have shown that peroxisome proliferator-activated receptor gamma(PPARγ)is a key signaling molecule in the treatment of insulin resistance.This article summarizes domestic and international literature on the intervention of insulin resistance through PPARγ signaling by traditional Chinese medicine(TCM)in recent years.It is found that the downstream signaling molecules targeted by PPARγ include nuclear factor kappa B(NF-κB),phosphoinositide 3-kinase(PI3K),uncoupling protein 1(UCP1),and liver X receptor alpha(LXR-α),which exert their effects in reducing body weight,lowering blood glucose and lipids,and improving insulin resistance by improving inflammation,oxidative stress,endoplasmic reticulum stress,and mitochondrial dysfunction in insulin-target organs.A total of 14 single TCM compounds and 7 TCM formulas have been identified to regulate the PPARγ signaling pathway to improve insulin resistance.This article aims to provide a theoretical basis for the treatment of insulin resistance and related diseases with TCM,and to offer new ideas for clinical research and new drug development.

参考文献/References:

[1] PARCHA V,HEINDL B,KALRA R,et al.Insulin resistance and cardiometabolic risk profile among nondiabetic American young adults:Insights from NHANES[J].J Clin Endocrinol Metab,2022,107(1):e25-e37.
[2] 施俊,葛志豪,任雅婷,等.不同性别社区人群体成分与胰岛素抵抗关联研究[J].现代预防医学,2024,51(12):2253-2261.
[3] CHEN H,TAN H,WAN J,et al.PPAR-gamma signaling in nonalcoholic fatty liver disease:Pathogenesis and therapeutic targets[J].Pharmacol Ther,2023,245:108391.
[4] CHEN F,MA L,LIU Q,et al.Recent advances and therapeutic applications of PPARgamma-targeted ligands based on the inhibition mechanism of Ser273 phosphorylation[J].Metabolism,2024,163:156097.
[5] WU M,WANG Q,LI X,et al.Gut microbiota-derived 5-hydroxyindoleacetic acid from pumpkin polysaccharides supplementation alleviates colitis via MAPKs-PPARgamma/NF-kappaB inhibition[J].Int J Biol Macromol,2024,264(Pt 1):130385.
[6] PASCHOAL V A,WALENTA E,TALUKDAR S,et al.Positive reinforcing mechanisms between GPR120 and PPARgamma modulate insulin sensitivity[J].Cell Metab,2020,31(6):1173-1188.
[7] LEE H S,HEO C U,SONG Y H,et al.Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes[J].Arch Pharm Res,2023,46(3):192-205.
[8] 王亮,刘安宁,李红玲,等.黄芩素调节PPARγ/LXRα/ABCA1信号通路干预NAFLD大鼠肝功能和胰岛素抵抗研究[J].现代医学,2023,51(1):17-23.
[9] 马浩洋,冯志海,任秋月,等.基于NF-κB信号通路探讨中药单体改善糖尿病周围神经病变机制[J].陕西中医,2024,45(11):1565-1569.
[10] ZHANG Z Z,YU X H,TAN W H.Baicalein inhibits macrophage lipid accumulation and inflammatory response by activating the PPARgamma/LXRalpha pathway[J].Clin Exp Immunol,2022,209(3):316-325.
[11] 梁倩倩,陈乙菲.益气固表丸含药血清对香烟烟雾提取物诱导的3T3-L1前脂肪细胞脂质积累及炎症的影响研究[J].陕西中医,2024,45(10):1305-1310.
[12] ZHAO T,JIA J.Polygalacic acid attenuates cognitive impairment by regulating inflammation through PPARgamma/NF-kappaB signaling pathway[J].CNS Neurosci Ther,2024,30(2):e14581.
[13] TANG Y,WEI K,LIU L,et al.Activation of PPARgamma protects obese mice from acute lung injury by inhibiting endoplasmic reticulum stress and promoting mitochondrial biogenesis[J].PPAR Res,2022,2022:7888937.
[14] PUIGHERMANAL E,LUNA-SANCHEZ M,GELLA A,et al.Cannabidiol ameliorates mitochondrial disease via PPARgamma activation in preclinical models[J].Nat Commun,2024,15(1):7730.
[15] THAM Y Y,CHOO Q C,MUHAMMAD T,et al.Lauric acid alleviates insulin resistance by improving mitochondrial biogenesis in THP-1 macrophages[J].Mol Biol Rep,2020,47(12):9595-9607.
[16] 张琦,田冲冲,张洋,等.灯盏花乙素通过PPARγ-PGC1α-UCP1通路改善小鼠肥胖作用及机制[J].药物评价研究,2024,47(8):1787-1796.
[17] CHEN N,ZHAO M,WU N,et al.ACSS2 controls PPARgamma activity homeostasis to potentiate adipose-tissue plasticity[J].Cell Death Differ,2024,31(4):479-496.
[18] MIRANDA C S,SILVA-VEIGA F M.PPARalpha/gamma synergism activates UCP1-dependent and-independent thermogenesis and improves mitochondrial dynamics in the beige adipocytes of high-fat fed mice[J].Nutrition,2024,117:112253.
[19] TANG H,ZENG Q,TANG T,et al.Kaempferide improves glycolipid metabolism disorder by activating PPARgamma in high-fat-diet-fed mice[J].Life Sci,2021,270:119133.
[20] GONG P,WANG J,WANG S,et al.Metabolomic analysis of the Puerarin hypoglycemic activity via AMPK-mTOR and PPARgamma-NF-kappaB signaling pathways[J].Phytomedicine,2024,130:155546.
[21] XU J,DONG J.Ginsenoside compound K inhibits obesity-induced insulin resistance by regulation of macrophage recruitment and polarization via activating PPARgamma[J].Food Funct,2022,13(6):3561-3571.
[22] ZHONG Y,LI Z,JIN R,et al.Diosgenin ameliorated type Ⅱ diabetes-associated nonalcoholic fatty liver disease through inhibiting de novo lipogenesis and improving fatty acid oxidation and mitochondrial function in rats[J].Nutrients,2022,14(23):329-331.
[23] XU Y,YU T,MA G,et al.Berberine modulates deacetylation of PPARgamma to promote adipose tissue remodeling and thermogenesis via AMPK/SIRT1 pathway[J].Int J Biol Sci,2021,17(12):3173-3187.
[24] AVILA D L,FERNANDES-BRAGA W,SILVA J L,et al.Capsaicin improves systemic inflammation,atherosclerosis,and macrophage-derived foam cells by stimulating PPAR gamma and TRPV1 receptors[J].Nutrients,2024,16(18):2512-2518.
[25] FERDOWSI P V,AHUJA K,BECKETT J M,et al.Capsaicin and zinc signalling pathways as promising targets for managing insulin resistance and type 2 diabetes[J].Molecules,2023,28(6):987-989.
[26] BALAKUMAR P,VENKATESAN K,ABDULLA K N,et al.Mechanistic insights into the beneficial effects of curcumin on insulin resistance:Opportunities and challenges[J].Drug Discov Today,2023,28(7):103627.
[27] CREMONINI E,DA S L,LANZI C R,et al.Anthocyanins and their metabolites promote white adipose tissue beiging by regulating mitochondria thermogenesis and dynamics[J].Biochem Pharmacol,2024,222:116069.
[28] SINHA K,KUMAR S,RAWAT B,et al.Kutkin,iridoid glycosides enriched fraction of Picrorrhiza kurroa promotes insulin sensitivity and enhances glucose uptake by activating PI3K/Akt signaling in 3T3-L1 adipocytes[J].Phytomedicine,2022,103:154204.
[29] LIU T,WANG J,TONG Y,et al.Integrating network pharmacology and animal experimental validation to investigate the action mechanism of oleanolic acid in obesity[J].J Transl Med,2024,22(1):86.
[30] ZHU K X,NIE S P,TAN L H,et al.A Polysaccharide from ganoderma atrum improves liver function in type 2 diabetic rats via antioxidant action and short-chain fatty acids excretion[J].J Agric Food Chem,2016,64(9):1938-1944.
[31] JI L,GU H.The anti-obesity effects of rhein on improving insulin resistance(IR)and blood lipid levels are involved in endoplasmic reticulum stress(ERs),inflammation,and oxidative stress in vivo and vitro[J].Bioengineered,2021,12(1):5797-5813.
[32] 程亚.基于棕色脂肪AMPK/ATGL通路探讨二陈汤抗肥胖机制[D].广州:广州中医药大学,2022.
[33] 李荣荣,杜航,李航,等.基于临床疗效挖掘和靶点网络验证的二陈汤治疗高脂血症燥湿化痰功效研究[J].中草药,2024,55(8):2708-2722.
[34] 刘佳璇.桑黄通泻方对糖尿病肾病大鼠的肾脏保护作用及PPARγ、NF-κB表达的影响[D].唐山:华北理工大学,2023.
[35] 张小清,许文华,肖鑫,等.葛根芩连汤促进糖尿病大鼠棕色脂肪分化改善糖脂紊乱的分子机制[J].中国中药杂志,2021,46(17):4462-4470.
[36] 郭胜男,张莉,吴深涛,等.化浊解毒方对多氯联苯126暴露致大鼠脂肪胰岛素抵抗的机制[J].中成药,2021,43(12):3303-3309.
[37] 张晴玥,许心蕊,冯露,等.基于PPARγ/NF-κB信号通路探讨四妙勇安汤对脂肪细胞炎症的作用机制研究[J].海南医学院学报,2024,30(18):1361-1369.
[38] 周涛涛,徐定昌,平菁,等.基于网络药理学研究活血调脂方对糖尿病性脂肪肝糖脂代谢的作用[J].中成药,2022,44(6):1993-1999.
[39] 李栋梁.糖脂平消汤加味对气阴两虚型代谢综合征模型大鼠脂肪因子的影响[D].郑州:河南中医药大学,2022.

相似文献/References:

[1]蔡之幸,陈 越△.小檗碱联合人参皂苷Rb1对脂肪细胞炎症信号通路作用*[J].陕西中医,2020,(3):297.
 CAI Zhixing,CHEN Yue..Effects of berberine and ginsenoside Rb1 on inflammatory signal transduction pathway in adipocytes[J].,2020,(5):297.
[2]庞苗苗,庞 羽,贺丰杰△.荷叶瓜蒌汤联合炔雌醇环丙孕酮片治疗多囊卵巢综合征临床研究[J].陕西中医,2020,(10):1373.[doi:DOI:10.3969/j.issn.1000-7369.2020.10.008]
[3]岳 悦,郑桂玲,褚月颉,等.四逆散合平胃散联合罗格列酮治疗代谢综合征疗效及对患者氧自由基水平的影响[J].陕西中医,2022,(4):479.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.017]
[4]雷 霏,高彩霞.小柴胡汤加减对代谢相关性脂肪性肝病患者肝功能及胰岛素抵抗的影响[J].陕西中医,2022,(7):890.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.018]
 LEI Fei,GAO Caixia.Effect of modified Xiaochaihu decoction on liver function and insulin resistance in patients with metabolic-related fatty liver disease[J].,2022,(5):890.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.018]
[5]赵心瑜,秦璐璐,刘文琼.基于脂代谢异常探讨从痰论治多囊卵巢综合征作用机制[J].陕西中医,2022,(7):921.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.026]
 ZHAO Xinyu,QIN Lulu,LIU Wenqiong.To explore the mechanism of treating polycystic ovary syndrome from phlegm based on abnormal lipid metabolism[J].,2022,(5):921.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.026]
[6]王 芬,何华亮,刘铜华,等.中药复方糖耐康对KKAy糖尿病小鼠低度炎症信号通路的影响[J].陕西中医,2022,(8):992.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.002]
 WANG Fen,HE Hualiang,LIU Tonghua,et al.Effects of traditional Chinese medicine of Tangnaikang on low-degree inflammatory signaling pathway in KKAy diabetic mice[J].,2022,(5):992.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.002]
[7]孔繁敏,顾昕怡,尹炳琪,等.电针对糖尿病大鼠海马区胰高血糖素样肽1的影响[J].陕西中医,2023,(3):275.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.001]
 KONG Fanmin,GU Xinyi,YIN Bingqi,et al.Effect of electroacupuncture on GLP-1 in hippocampus of diabetic rats[J].,2023,(5):275.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.001]
[8]陈 莉,赵 伟,李光美,等.兰连糖毒清汤对糖尿病小鼠胰岛素抵抗及NALP3炎症体的影响[J].陕西中医,2023,(4):411.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.001]
 CHEN Li,ZHAO Wei,LI Guangmei,et al.Effects of Lanlian Tangduqing decoction on insulin resistance and NALP3 inflammatory body in diabetes mellitus mice[J].,2023,(5):411.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.001]
[9]朱海慧,李 静,刘亚东,等.三黄化糖饮联合西药治疗痰热互结型2型糖尿病疗效研究[J].陕西中医,2023,(4):467.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.013]
 ZHU Haihui,LI Jing,LIU Yadong,et al.Clinical study on the effect of Sanhuang Huatang decoction on type 2 diabetes mellitus with phlegm-heat interaction syndrome[J].,2023,(5):467.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.013]
[10]何 霞,卿媛媛,常嘉昱,等.黄连-肉桂配比对慢性心力衰竭大鼠下丘脑-垂体-肾上腺轴的影响[J].陕西中医,2023,(11):1523.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.006]
 HE Xia,QING Yuanyuan,CHANG Jiayu,et al.Effect of proportions of Huanglian Rougui ratio in rats with chronic heart failure based on hypothalamic-pituitary-adrenal axis[J].,2023,(5):1523.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.006]

备注/Memo

备注/Memo:
[基金项目]国家自然科学基金资助项目(82205060); 黑龙江省自然科学基金委员会2020联合引导项目(LH2020H085); 教育部“春晖计划”合作科研项目(HLJ2019038)
更新日期/Last Update: 2025-05-08